Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu Kartik MohantyAsim SahaMalaya Bhattacharya-Chatterjee Preclinical study 27 September 2006 Pages: 1 - 11
MDA-MB-435 cells are derived from M14 Melanoma cells––a loss for breast cancer, but a boon for melanoma research James M. RaeChad J. CreightonMichael D. Johnson Preclinical Study 27 September 2006 Pages: 13 - 19
Over-expression of genes and proteins of ubiquitin specific peptidases (USPs) and proteasome subunits (PSs) in breast cancer tissue observed by the methods of RFDD-PCR and proteomics Shishan DengHongying ZhouHuijun Yang Preclinical Study 27 September 2006 Pages: 21 - 30
Different criteria for HER2 positivity by IHC can be applied in post-chemotherapy specimens in determining HER2 as a prognosticator in locally advanced breast cancer Yong Wha MoonHei-Cheul JeungHyun Cheol Chung CLINICAL TRIAL 15 February 2007 Pages: 31 - 37
Health-related quality of life in long-term breast cancer survivors: Nationwide survey in Denmark Vera PeuckmannOla EkholmPer Sjøgren Epidemiology 29 September 2006 Pages: 39 - 46
Ethnic and geographic differences in mammographic density and their association with breast cancer incidence Gertraud MaskarinecIan PaganoInger Torhild Gram Epidemiology 29 September 2006 Pages: 47 - 56
A strong association between body fat mass and protein profiles in nipple aspirate fluid of healthy premenopausal non-lactating women Yafei HuangManubai NagamaniLee-Jane W. Lu Epidemiology 27 September 2006 Pages: 57 - 66
The 3′ untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation Anna JakubowskaJacek GronwaldUte Hamann Epidemology 27 September 2006 Pages: 67 - 74
Estrogen receptor-β regulates psoriasin (S100A7) in human breast cancer George P. SklirisAnthony LewisLeigh C. Murphy Original Paper 29 September 2006 Pages: 75 - 85
Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging Leilani MoralesSteven PansPatrick Neven Original paper 24 October 2006 Pages: 87 - 91
Fluvastatin enhancement of trastuzumab and classical cytotoxic agents in defined breast cancer cell lines in vitro Daniel R. BudmanJulia TaiAnthony Calabro Original Paper 27 September 2006 Pages: 93 - 101
Nuclear morphometric features in benign breast tissue and risk of subsequent breast cancer Yan CuiEsther A. KoopThomas E. Rohan Original Paper Open access 24 October 2006 Pages: 103 - 107
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF Catharina WenzelRupert BartschGuenther G. Steger Original Paper 24 October 2006 Pages: 109 - 114
